Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Controlled Study of the Efficacy and Acceptability of a Pharmacogenetic Test in the Management of Patients Treated With Escitalopram.

NCT06210321 is registered in ClinicalTrials.gov with Chantal Csajka as lead sponsor.

NCT NCT06210321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06210321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Controlled Study of the Efficacy and Acceptability of a Pharmacogenetic Test in the Management of Patients Treated With Escitalopram.
Lead sponsor
Chantal Csajka
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 15, 2025
Completion date
August 14, 2027
Enrollment
270 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacogenetic testing